Evidence map›Paper›PMID 30884834›Full record

ReviewNutrients2019

Non-Nutritive Sweeteners and Their Implications on the Development of Metabolic Syndrome.

Iryna Liauchonak, Bessi Qorri, Fady Dawoud, Yatin Riat, Myron R Szewczuk

Open access · goldAbstract readReview
In one paragraph

Review in Nutrients, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed, 2 pooled it
7.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 2 syntheses or guidelines pooled it, 112 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Iryna LiauchonakGraduate Diploma and Professional Master in Medical Sciences, Postgraduate Medical Education, School of Medicine, Queen's University, Kingston, ON K7L 3N6, Canada. iryna.liauchonak@gmail.com.ORCID 0000-0002-7501-8550
Bessi QorriDepartment of Biomedical and Molecular Sciences, Queen's University, Kingston, ON K7L 3N6, Canada. bessi.qorri@queensu.ca.ORCID 0000-0003-4984-7299
Fady DawoudGraduate Diploma and Professional Master in Medical Sciences, Postgraduate Medical Education, School of Medicine, Queen's University, Kingston, ON K7L 3N6, Canada. Fady.Dawoud@hotmail.com.
Yatin RiatGraduate Diploma and Professional Master in Medical Sciences, Postgraduate Medical Education, School of Medicine, Queen's University, Kingston, ON K7L 3N6, Canada. riatyatin@gmail.com.
Myron R SzewczukDepartment of Biomedical and Molecular Sciences, Queen's University, Kingston, ON K7L 3N6, Canada. szewczuk@queensu.ca.ORCID 0000-0001-8471-5481
Queen's University · CA

Funding

Natural Sciences and Engineering Research Council of Canada NSERC RGPIN-2015-05301
6 · The paper itself

Abstract

Individuals widely use non-nutritive sweeteners (NNS) in attempts to lower their overall daily caloric intake, lose weight, and sustain a healthy diet. There are insufficient scientific data that support the safety of consuming NNS. However, recent studies have suggested that NNS consumption can induce gut microbiota dysbiosis and promote glucose intolerance in healthy individuals that may result in the development of type 2 diabetes mellitus (T2DM). This sequence of events may result in changes in the gut microbiota composition through microRNA (miRNA)-mediated changes. The mechanism(s) by which miRNAs alter gene expression of different bacterial species provides a link between the consumption of NNS and the development of metabolic changes. Another potential mechanism that connects NNS to metabolic changes is the molecular crosstalk between the insulin receptor (IR) and G protein-coupled receptors (GPCRs). Here, we aim to highlight the role of NNS in obesity and discuss IR-GPCR crosstalk and miRNA-mediated changes, in the manipulation of the gut microbiota composition and T2DM pathogenesis.

Indexed as

Diabetes Mellitus, Type 2DysbiosisGastrointestinal MicrobiomeHumansMetabolic SyndromeMicroRNAsNon-Nutritive SweetenersObesityReceptor, InsulinReceptors, G-Protein-CoupledMicroRNAsNon-Nutritive SweetenersReceptor, InsulinReceptors, G-Protein-CoupledGPCRgut microbiotainsulin receptor signalingmiRNAsnon-nutritive sweetenerstype 2 diabetes mellitus

Identifiers

PMID30884834
PMCPMC6471792
OpenAlexW2921587976

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.